Abstract
It is well established that species differences in toxicity and carcinogenicity of xenobiotics are often based on species-specific metabolism. Hence, the use of pharmacokinetic models considering relevant metabolic routes may considerably improve risk assessment procedures (Bolt, 1987; Travis, 1987). The biological basis for an appropriate interspecies extrapolation is knowledge of the biochemical mode of action and of the toxicologically relevant metabolic pathways. This will be exemplified by a discussion of major halogenated industrial solvents and of 1,3-butadiene. Long-term animal bioassays with these compounds have demonstrated considerable differences between the two most widely used animal species, mice and rats. This review will not consider 1,1,1trichloroethane. This solvent is metabolized in man and in experimental animals to a very low extent only (up to 5–10% of the inhaled dose), and no positive carcinogenicity data have hitherto been obtained. However, the closely related compounds 1,1,2-trichloroethane and 1,1,2,2-tetrachloroethane which are extensively metabolized have produced liver tumors in mice (Baseman et al., 1984).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ahmed, A.E., and Anders, M., 1976, Metabolism of dihalomethane to formaldehyde and inorganic halides., In vitro studies, Drug. Metab. Disposition 4:357–361.
Anders, M.W., Kubic, V.L., and Ahmed, A.E., 1977, Metabolism of halogenated methanes and macromolecular binding, J. Env. Pathol. Toxicol., 1:117–124.
Andersen, M.E., Clewell, J.E., Gargas, M.L., Smith, F.A., and Reitz, R.H., 1987, Physiologically based pharmacokinetics and the risk assessment process for methylene chloride, Toxicol. Appl. Pharmacol., 87:185.
Bergman, K., 1983, Interactions of trichlormethylene with DNA in vitro and with RNA and DNA in various mouse tissues in vivo, Arch. Toxicol., 54:181–193.
Bolt, H.M., 1987, Pharmacokinetic factors and their implication in the induction of mouse liver tumours by halogenated hydrocarbons,Arch. Toxicol., Suppl., 10:190.
Bolt, H.M., Laib, R.J., and Fílser, J.G., 1982, Reactive metabolites and carcinogenicity of halogenated ethylenes, Biochem. Pharmacol., 31:1–4.
Bolt, H.M., and Link, B., 1980, Zur Toxikologie von Perchloräthylen, Verh. Dtsch. Ges. Arbeitsmed. (Gentner, Stuttgart), 2:463–470.
Bolt, H.M., Buchter A., Wolowski, L., Gil, D.L., and Bolt, W., 1977, Incubation of f4C-trichlorethylene vapor with rat liver microsomes: uptake of radioactivity and covalent protein binding of metabolites, Int. Arch. Env. Occup. Hlth., 39:102–111.
Bolt, H.M., Fílser, J.G., and Störmer, F., 1984, Inhalation pharmacokinetics based on gas uptake studies. V. Comparative pharmacokinetics of ethylene and 1,3-butadiene in rats, Arch. Toxicol“ 55:213–218.
Bond, J.A., Dahl, A.R., Henderson, R.F., Dutcher, J.S., Mauderly, J.L., and Birnbaum, L.S., 1986, Species differences in the disposition of inhaled butadiene, Toxicol. Appl. Pharmacol., 84:617–627.
Citti, L., Gervasi, P.G., Turchi, G., Belluci, G., and Bianchini, R., 1984, The reaction of 3,4-epoxy-l-butene with deoxyguanosine and DNA in vitro: synthesis and characterization of the main adducts, Carcinogenesis, 5:47–52.
Cooper, P., 1978, Trichloroethylene: hepatic effects, metabolism and elimination, Fd. Cosmet. Toxicol., 16:491–492.
Costa, A.K., and Ivanetich, K.M., 1980, Tetrachloroethylene metabolism by the hepatic microsomal cytochrome P-450 system, Biochem. Pharmacol., 29:2863–2869.
Dekant, W., 1986, Metabolic conversion of tri-and tetrachloroethylene: formation and deactivation of genotoxic intermediates. In: New Concepts and Developments in Toxicology, P.L. Chambers, P. Gehring, and F. Sakai, eds., pp. 211–221, Elsevier Science Publishers, Amsterdam, New York, Oxford.
Dekant, W., Schulz, A., Metzler, M., and Henschler, D., 1986, Absorption, elimination and metabolism of trichloroethylene: a quantitative comparison between rats and mice, Xenobiotica, 16:143–152.
Dekant, W., Vamvakas, S., Berthold, K., Schmidt, S., Wild, D., and Henschler, D., 1986, Bacterial beta-lyase cleavage and mutagenicity of cysteine conjugates derived from the nephrocarcinogenic alkenes trichloroethylene, tetrachloroethylene and hexachlorobutadiene, Chem. biol. Interact., 60:31–45.
Dekant, W., Metzler, M., and Henschler, D., 1986a, Identification of S1,2-divinyl-N-acetyl-cysteine as a urinary metabolite of trichloroethylene: a possible explanation for its nephrocarcinogenicity in male rats, Biochem. Pharmacol., 35:2455–2458.
Dekant, W., Metzler, M., and Henschler, D., 1986b, Identification of S1,2,2-trichlorovinyl-N-acetyl-cysteine as a urinary metabolite of tetrachloroethylene: bioactivation through glutathione conjugation as a possible explanation of its nephrocarcinogenicity, J. Biochem. Toxicol., 1 (2):57–72.
Dekant, W., Metzler, M., and Henschler, D., 1984, Novel metabolites of trichloroethylene through dechlorination reactions in rats, mice and humans, Biochem. Pharmacol., 33:2021–2027.
Elcombe, C.R., Rose, M.S., and Pratt, I.S., 1985, Biochemical, histological, and ultrastructural changes in rat and mouse liver following the administration of trichloroethylene: possible relevance to species differences in hepatocarcinogenicity, Toxicol. Appl. Pharmacol., 79:365–376.
Filser, J.G., and Bolt, H.M., 1979, Pharmacokinetics of halogenated ethylenes in rats, Arch. Toxicol., 42:123–126.
Filser, J.G., and Bolt, H.M., 1984, Inhalation pharmacokinetics based on gas uptake studies. VI. Comparative evaluation of ethylene oxide and butadiene monoxide as exhaled reactive metabolites of ethylene and 1,3-butadiene in rats, Arch. Toxicol., 55:219–223.
Gargas, M.L., Clewell, H.J., and Andersen, M.E., 1986, Metabolism of inhaled dihalomethanes in vivo: differentiation of kinetic constants for two independent pathways, Toxicol. Appl. Pharmacol., 82:211.
Gervasi, P.G., Citti, L., Del Monte, M., Longo, V., and Benetti, D., 1985, Mutagenicity and chemical reactivity of epoxidic intermediates of the isoprene metabolism and other structurally related compounds, Mutation Res., 156:77–82.
Green, T., and Prout, M.S., 1985, Species differences in response to trichloroethylene. II. Biotransformation in rats and mice, Toxicol. Appl. Pharmacol., 79:404–411.
Green, T., Nash, J.A., and Proven, W.M., 1986, Comparative pharmacokine-’ tics of inhaled dichloromethane in rats and mice, Abstract, Annual Meeting of the Society of Toxicology (SOT).
Haseman, J.K., Crawford, D.D., Huff, J.E., Boorman, G.A., and McConnell, E.E., 1984, Results from 86 two-year carcinogenicity studies conducted by the National Toxicology Program, J. Toxicol. Env. Hlth., 14:621–639.
Hassall, C.D., Gandolfi, A.J., Duhamel, R.C., and Brendel, K., 1984, The formation and biotransformation of cysteine conjugates of halogenated ethylenes by rabbit renal tubules, Chem. Biol. Interact., 49:283–297.
Hathway, D.E., 1980, Consideration of the evidence for mechanisms of 1,1,2-trichloroethylene metabolism, including new identification of its dichloroacetic acid and trichloroacetic acid metabolites in mice, Cancer Lett., 8:263–269.
Hazleton Laboratories Europe, 1981, 1,3-Butadiene. Inhalation study in the rat. Report No. 2788–522/3, Hazleton Labs., Harrowgate, England.
Henschler, D., 1977, Metabolism of chlorinated alkenes and alkane as related to toxicity, J. Environ. Pathol. Toxicol., 1:125–133.
Henschler, D., and Hoos, R., 1982, Metabolic activation and deactivation mechanisms of di-, tri-, and tetrachloroethylenes, in: Snyder, R. et al. (eds.) Biological Reactive Intermediates - II, part A, Plenum Publishing Corporation, pp. 659–666.
Herren-Freund, S.L., Pereira, M.A., Khoury, M.D., and Olson, G., 1987, The carcinogenicity of trichloroethylene and its metabolites, trichloroacetic acid and dichloroacetic acid, in mouse liver, Toxicol. Appl. Pharmacol., 90:183–189.
Huff, J.E., Melnick, R.L., Solleveld, H.A., Hasemann, J.K., Power, M., and Miller, R.A., 1985, Multiple organ carcinogenicity of 1,3-butadiene in B6C3F1 mice after 60 weeks of inhalation exposure, Science, 277:548–549.
Ikeda, M., and Ohtsuji, H., 1972, A comparative study of the excretion of Fujiwara reaction-positive substances in urine of humans and rodents given trichloro-or tetrachloro-derivatives of ethane and ethylene, Brit. J. Ind. Med., 29:99–104.
Ivanetich, K.M., and van den Honert, L.H., 1981, Chloroethanes: their metabolism by hepatic cytochrome P-450 in vitro, Carcinogenesis, 2:697–702.
Ketterer, B., 1986, Detoxication reactions of glutathione and glutathione transferases, Xenobiotica, 16:957–973.
Kreiling, R., Laib, R.J., Falser, J.G., and Bolt, H.M., 1986, Species differences in butadiene metabolism between mice and rats evaluated by inhalation pharmacokinetics, Arch. Toxicol., 58:235–238 (1986).
Kreiling, R., Laib, R.J., Falser, J.G., and Bolt, H.M., 1987, Inhalation pharmacokinetics of 1,2-epoxybutene-3 reveal species differences between rats and mice sensitive to butadiene induced carcinogenesis, Arch. Toxicol., 61:7–11.
Kubic, V.L., and Anders, M.W., 1978, Metabolism of dihalomethanes to carbon monoxide. III. Studies on the mechanism of the reaction, Biochem. Pharmacol., 27:2349–2355.
Kurppa, K., and Vainio, H., 1981, Effects of intermittent dichloromethane inhalation on blood carboxyhemoglobin concentration and drug metabolizing enzymes in rat, Res. Commun. Chem. Pathol. Pharmacol., 32:535–544.
Laib, R.J., Stöckle, G., Bolt, H.M., and Kunz, W., 1979, Vinyl chloride and trichloroethylene: comparison of alkylating effects of metabolites and induction of preneoplastic enzyme deficiencies in rat liver, J. Cancer Res. Clin. Oncol., 94:134–147.
Laib, R.J., 1982, Specific covalent binding and toxicity of aliphatic halogenated xenobiotics, in: “ Reviews on Drug Metabolism and Drug Interactions”, Vol. 5, No. 1, Beckett, A.H. and Gorrod, J.W., eds., pp. 1–48, Freund Publishing House Ltd., London.
Laib, R.J., Falser, J.G., Kreiling, R., Vangala, R.R., and Bolt, H.M., 1988, Inhalation pharmacokinetics of 1,3-butadiene and 1,2-epoxybutene-3 in rats and mice, Environ. Hlth. Perspect., in press.
Malvoisin, E., and Roberfroid, M., 1982, Hepatic microsomal metabolism of 1,3-butadiene, Xenobiotica, 12:137–144.
McKenna, M.J., and Zempel, J.A., 1981, The dose-dependent metabolism of C-methylene chloride following oral administration to rats, Fd. Cosmet. Toxicol., 19:73–78.
McKenna, M.J., Zempel, J.A., and Braun, W.A., 1982, The pharmacokinetics of inhaled methylene chloride in rats, Toxicol. Appl. Pharmacol., 65:1–10.
Miller, R.E., and Guengerich, F.P., 1982, Oxidation of trichloroethylene by liver microsomal cytochrome P-450: evidence for chlorine migration in a transition state not involving trichloroethylene oxide, Biochemistry, 21:1090–1097.
Mitchell, A.M., Bridges, J.W., and Elcombe, C.R., 1984, Factors influencing peroxisome proliferation in cultured rat hepatocytes, Arch. Toxicol., 55:239–246.
NIEHS, 1988, International Symposium on the Toxicology, Carcinogenesis, and Human Health Aspects of 1,3-Butadiene, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina, USA, April 12–13.
NTP, 1986, Toxicology and carcinogenesis of tetrachloroethylene (perchloroethylene) in F 344/N rats and B6C3F1 mice (inhalation studies), NTP-TR311, US Dept. of Health & Human Services, Washington, DC.
Ohtsuki, T., Sato, K., Koizumi, A., Kumai, M., and Ikeda, M., 1983, Limited capacity of humans to metabolize tetrachloroethylene, Int. Arch. Occup. Environ. Hlth., 51:381–390.
Parchman, I.G. and Magee, P.N., 1982, Metabolism of 14C-trichloroethy-lene to í4CO2 and interaction of a metabolite with DNA of rats and mice, J. Toxicol. Environ. Hlth., 9:797–813.
Pegg, D.G., Zempel, J.A., Braun, W.H., and Watanabe, P.G., 1979, Disposition of tetrachloro(14C)ethylene following oral and inhalation exposure in rats, Toxicol. Appt. Pharmacol., 51:455–474.
Prout, M.S., Provan, W.M., and Green, T., 1985, Species differences in response to trichloroethylene. I. Pharmacokinetics in rats and mice, Toxicol. Appl. Pharmacol., 79:389–300.
Reichert, D., 1983, Biological actions and interactions of tetrachloroethylene, Mutation Res., 123:411–429.
Reichert, D., Werner, H.W., Metzler, M., and Henschler, D., 1979, Molecular mechanism of 1,1-dichloroethylene toxicity: excreted metabolites reveal different pathways of reactive metabolites, Arch. Toxicol., 42:159–169.
Rodkey, F.L., and Collison, H.A., 1977, Biological oxidation of 14C-methylene chloride to carbon monoxide and carbon dioxide by the rat, Toxicol. Appl. Pharmacol., 40:33–38.
Schumann, A.M., Quast, J.F., and Watanabe, P.G., 1980, The pharmacokinetics and macromolecular interactions of perchloroethylene in mice and rats as related to oncogenicity, Toxicol. Appl. Pharmacol., 55:207–219.
Stevens, J.L., Ratnayake, J.H., and Anders, M.W., 1980, Metabolism of dihalomethanes to carbon monoxide. IV. Studies in isolated rat hepatocytes, Toxicol. Appl. Pharmacol., 55:484–489.
Stoff, W.T., Quast, J.F., and Watanabe, P.G., 1982, The pharmacokinetics and macromolecular interactions of trichloroethylene in mice and rats, Toxicol. Appl. Pharmacol., 62:137–151.
Travis, C.C., 1987, Interspecies extrapolations in risk analysis, Toxicology, 47:3.
Vamvakas, S., Dekant, W., Berthold, K., Schmidt, S., Wild, D., and Henschler, D., 1987, Enzymatic transformation of mercapturic acids derived from halogenated alkenes to reactive and mutagenic intermediates, Biochem. Pharmacol., 36:2741–2748.
Yllner, S., 1971a, Metabolism of 1,1,2-trichloroethane-1,2-14C in the mouse, Acta pharmacol. toxicol., 30:248–256.
Yllner, S., 1971b, Metabolism of 1,1,2,2-tetrachloroethane-1,2-14C in the mouse, Acta pharmacol. toxicol., 29:499–512.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Plenum Press, New York
About this chapter
Cite this chapter
Bolt, H.M., Laib, R.J. (1989). Biological Basis for Interspecies Extrapolations of Halogenated Solvents and of 1,3-Butadiene. In: Travis, C.C. (eds) Biologically Based Methods for Cancer Risk Assessment. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5625-7_9
Download citation
DOI: https://doi.org/10.1007/978-1-4684-5625-7_9
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-5627-1
Online ISBN: 978-1-4684-5625-7
eBook Packages: Springer Book Archive